Previously, others have shown that breast tumors suppress cDC1 development from DC progenitors, resulting in decreased cDC1 abundance and reduced CD8+ T cell-mediated anti-tumor immunity [36]. The gene discussed is MPPE1; the disease is breast neoplasm.